747-303: A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multi-center Study evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis.

-
Investigator: Muhammad Y. Sheikh, MD

Location(s): United States

Description

The primary objectives of this study are to evaluate the effect of Obeticholic Acid treatment compared to placebo on 1) histological improvement and 2) liver-related clinical outcomes in patients with non-cirrhotic nonalcoholic steatohepatitis (NASH) with liver fibrosis.